Phase 1 Safety Study of ALK-001 in Healthy Volunteers
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This protocol is a phase 1 clinical study to assess the safety and pharmacokinetics of
ALK-001 in healthy volunteers. Please contact [email protected] for any questions.